Mitsubishi Chemical Group Corporation [4091.T]
TOKYO, Apr 30 (Pulse News Wire) – Mitsubishi Chemical Group Corporation (4091.T) announced today that its subsidiary, Japan Oxygen Holdings Co., Ltd. (NSHD; code: 4,091), completed the acquisition of Esteve Teijin Healthcare, S.L.
On March 03, 2026, renaming the company to Nippon Sanso Homecare España, S.L.U. Following the acquisition, NSHD discovered that the newly acquired company's capital stock exceeded 10% of Mitsubishi Chemical’s total capital, making it a significant subsidiary. Nippon Sanso Homecare España, S.L.U. operates in home healthcare services in Spain, with its headquarters located at Passeig del Ferrocarril, 369 P. I.
Camí Ral, 08860 Castelldefels, Barcelona, Spain. The company was established in February 2009 and is now wholly owned by Oximesa S.L.U., which is itself a subsidiary of NSHD. Its capital stock stands at ¥35.7 million euros. In recent years, the company reported steady growth in revenue, increasing from ¥33 million euros in fiscal 2022 to ¥40 million euros in fiscal 2024. Operating profit remained relatively stable, ranging from ¥3 million to ¥4 million euros during the same period.
Looking ahead, Mitsubishi Chemical stated that the impact of this acquisition has been incorporated into their forecast for the fiscal year ending March 2026, as previously disclosed on February 5, 2026.
🟡 Confidence: Standard AI-translated content.